Back
Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
50
APLS
Apellis Pharmaceuticals
Last Price:
29.28
Seasonality Move:
20.78%
Buy
58
EYPT
EyePoint Pharmaceuticals
Last Price:
11.14
Seasonality Move:
27.28%
Sell
50
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.58. The Score for APLS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $11.99. The Score for EYPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.58
The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $11.99
The current trend is moderately bullish and EYPT is experiencing slight buying pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 54.99 | Buy |
Chaikin Money Flow: | -1641686 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.93 - 28.59) | Buy |
Bollinger Bands (100): | (29.6 - 39.46) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.72 | Buy |
Relative Strength Index (14 RSI): | 61.99 | Buy |
Chaikin Money Flow: | 102186 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.31 - 11.89) | Buy |
Bollinger Bands (100): | (8.02 - 10.36) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.63 | Buy |
20-day SMA: | 27.93 | Buy |
50-day SMA: | 31.05 | Sell |
200-day SMA: | 44.03 | Sell |
8-day EMA: | 28.82 | Buy |
20-day EMA: | 28.54 | Buy |
50-day EMA: | 30.64 | Sell |
200-day EMA: | 40.53 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.8 | Buy |
20-day SMA: | 11.12 | Buy |
50-day SMA: | 9.51 | Buy |
200-day SMA: | 14.36 | Sell |
8-day EMA: | 11.67 | Buy |
20-day EMA: | 11.03 | Buy |
50-day EMA: | 10.12 | Buy |
200-day EMA: | 11.65 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.50 per share.
Apellis Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |